<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">422</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORTHOPAEDIC PATHOMORPHOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРТОПЕДИЧЕСКАЯ ПАТОМОРФОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Notochordal tumors (chordoma). Differential diagnosis. Immunohistochemical markers</article-title><trans-title-group xml:lang="ru"><trans-title>Опухоли нотохорды (хордома/доброкачественная опухоль нотохорды). Дифференциальный диагноз. Иммуногистохимические маркеры в помощь диагностике</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Boulytcheva</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Булычева</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><email>irena@boulytcheva.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bertoni</surname><given-names>Franco</given-names></name><address><country country="IT">Italy</country></address><bio xml:lang="ru"><p>MD</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bacchini</surname><given-names>Patrizia</given-names></name><name xml:lang="ru"><surname>Баччини</surname><given-names>Патриция</given-names></name></name-alternatives><address><country country="IT">Italy</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Musaev</surname><given-names>E. R.</given-names></name><name xml:lang="ru"><surname>Мусаев</surname><given-names>Э. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>г. Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»</institution></aff></aff-alternatives><aff id="aff2"><institution>Casa di Cura Villa Erbosa University of Bologna</institution></aff><pub-date date-type="pub" iso-8601-date="2015-04-23" publication-format="electronic"><day>23</day><month>04</month><year>2015</year></pub-date><volume>7</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>31</fpage><lpage>35</lpage><history><date date-type="received" iso-8601-date="2022-01-23"><day>23</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-01-23"><day>23</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Boulytcheva I.V., Bertoni F., Bacchini P., Musaev E.R.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Булычева И.В., Bertoni F., Баччини П., Мусаев Э.Р.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Boulytcheva I.V., Bertoni F., Bacchini P., Musaev E.R.</copyright-holder><copyright-holder xml:lang="ru">Булычева И.В., Bertoni F., Баччини П., Мусаев Э.Р.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/422">https://sarbon.abvpress.ru/jour/article/view/422</self-uri><abstract xml:lang="en"><p>Chordomas, low-grade chondrosarcomas, metastatic carcinomas share many histological features, generating at times, considerable diagnostic difficulty and, not infrequently, requiring immunohistochemical analysis for appropriate classification. In an effort to clarify the diagnosis and differentiation with other cartilaginous tumors, samples from 58 patients with sacrum chordoma were examined by immunohistochemistry with a panel of antibodies. The panel included antibodies to cytokeratin (CK), epithelial membrane antigen (EMA), D2-40, GFAP (glial fibrillary acidic protein), NSE (neuron-specific enolase), chromogranin, TTF-1 (thyroid transcription factor), PSA, CDX-2, mammaglobin. The conventional chordoma stained for CK (16/16) EMA (13/16), NSE (12/16) and was negative for chromogranin, GFAP. Specific markers were helpful in differential with metastatic carcinomas. Chordomas are difficult to excise because of their location and intimate relation to critical structures. Two cases of dedifferentiated chordoma were described.</p></abstract><trans-abstract xml:lang="ru"><p>Хордома представляет собой специфическую мезенхимальную опухоль со своеобразными клиническими и морфологическими проявлениями. По гистологическому строению хордома напоминает нотохорду. Изучено 58 случаев хордомы крестца у 28 мужчин и 30 женщин в возрасте от 32 до 72 лет. В двух наблюдениях диагностирована дедифференцированная форма заболевания. Важным в диагностике хордомы оказался иммуногистохимический метод, выявляющий экспрессию цитокератинов, EMA, GFAP, NSE, brachyury. Отрицательные реакции с хромогранином, D2-40, а также органоспецифическими белками TTF-1, mammaglobin, PSA, CDX-2 позволяли исключить хордому и выявить метастазы рака различной локализации. Приведен пример дифференциальной диагностики с доброкачественной опухолью нотохорды / рудиментарными островками ткани нотохорды.</p></trans-abstract><kwd-group xml:lang="en"><kwd>notochordal tumors</kwd><kwd>cytokeratines</kwd><kwd>chromogranin A</kwd><kwd>EMA</kwd><kwd>GFAP</kwd><kwd>NSE</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нотохорда</kwd><kwd>цитокератины</kwd><kwd>хромогранин А</kwd><kwd>EMA</kwd><kwd>GFAP</kwd><kwd>NSE</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Mitchell A., Scheithauer B.W., Unni K.K. et al. Chordoma and chondroid neoplasms of the spheno-occiput. A immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer. 1993, v. 72, No. 10, p. 2943-2949.</mixed-citation><mixed-citation xml:lang="ru">Mitchell A., Scheithauer B.W., Unni K.K. et al. Chordoma and chondroid neoplasms of the spheno-occiput. A immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer. 1993, v. 72, No. 10, p. 2943-2949.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Hoch B.L., Nielsen G.P., Liebsh N.G. et al. Base of skull Chordomas in children and adolescents; a clinicopathologic study of 73 cases. Am. J. Surg. Pathol. 2006, v. 30, No. 70, p. 811-818.</mixed-citation><mixed-citation xml:lang="ru">Hoch B.L., Nielsen G.P., Liebsh N.G. et al. Base of skull Chordomas in children and adolescents; a clinicopathologic study of 73 cases. Am. J. Surg. Pathol. 2006, v. 30, No. 70, p. 811-818.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Kyriakos M., Totty W.G., Lenke L.G. Giant vertebral notochordal rest: a lesion distinct from chordoma: discussion of an evolving concept. Am. J. Surg. Pathol. 2003, v. 27, No. 3, p. 396-406.</mixed-citation><mixed-citation xml:lang="ru">Kyriakos M., Totty W.G., Lenke L.G. Giant vertebral notochordal rest: a lesion distinct from chordoma: discussion of an evolving concept. Am. J. Surg. Pathol. 2003, v. 27, No. 3, p. 396-406.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Yamaguchi T., Suzuki S., Ishiiwa H. et al. Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestides of fetal intervertebral discs. Am. J. Surg. Pathol. 2004, v. 28, p. 756-761.</mixed-citation><mixed-citation xml:lang="ru">Yamaguchi T., Suzuki S., Ishiiwa H. et al. Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestides of fetal intervertebral discs. Am. J. Surg. Pathol. 2004, v. 28, p. 756-761.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Almefty K., Pravdenkova S., Colli B.O. et al. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer. 2007, v. 110, No. 11, p. 2457-2467.</mixed-citation><mixed-citation xml:lang="ru">Almefty K., Pravdenkova S., Colli B.O. et al. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer. 2007, v. 110, No. 11, p. 2457-2467.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Fuchs B., Dickey I.D., Yaszemski M.J. et al. Operative management of sacral chordoma. J. Bone Joint Surg. Am. 2005, v. 87, No. 10, p. 2211-2216.</mixed-citation><mixed-citation xml:lang="ru">Fuchs B., Dickey I.D., Yaszemski M.J. et al. Operative management of sacral chordoma. J. Bone Joint Surg. Am. 2005, v. 87, No. 10, p. 2211-2216.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. O’Hara B.J., Paetau A., Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum. Pathol. 1998, v. 29, No. 2, p. 119-126.</mixed-citation><mixed-citation xml:lang="ru">O’Hara B.J., Paetau A., Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum. Pathol. 1998, v. 29, No. 2, p. 119-126.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Cho H.Y., Lee M., Takei H. et al. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, chordoid meningioma. Appl. Immunoch</mixed-citation><mixed-citation xml:lang="ru">Cho H.Y., Lee M., Takei H. et al. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, chordoid meningioma. Appl. Immunoch</mixed-citation></citation-alternatives></ref></ref-list></back></article>
